UHD's science building has received funding from a nonprofit affiliate of Green Mountain Energy to install green energy technology. Courtesy of NRG

The University of Houston-Downtown has gotten some green to make its new College of Sciences & Technology Building even more green.

The Green Mountain Energy Sun Club, a nonprofit affiliated with the Green Mountain Energy utility provider, has pledged more than $250,000 to UHD for installation of solar panels at the building, as well as the purchase of photosynthesis equipment.

Akif Uzman, dean of UHD's College of Sciences & Technology, says in a release that the Green Mountain Energy Sun Club gift propels "our drive to show students and our local community our commitment to energy conservation and sustainable energy practices."

By the spring of 2020, UHD will install a 54-panel, 16.7-kilowatt, off-grid solar system that will help power two environmental science teaching labs in the College of Sciences & Technology Building. One of the labs, the Green Mountain Energy Sun Club Environmental Science Lab, will host classes by next year's spring semester.

"Our mission is to change the way power is made, and we share UHD's dedication to renewable energy, environmental education, and reducing carbon emissions," Mark Parsons, vice president and general manager of Houston-based Green Mountain Energy, says in a release.

Houston-based NRG Energy owns Green Mountain Energy.

Donations to the Sun Club come from Green Mountain Energy and its customers and employees. Since 1997, Green Mountain Energy has promoted energy efficiency, conservation, and environmental stewardship.

The Sun Club gift also will help buy a portable photosynthesis system. Michael Tobin, associate professor of biology, says the equipment will take measurements of plants in courses such as Plant Biology Laboratory, General Ecology Laboratory, and Environmental Lab and Field Studies. In addition, it will be used by students conducting faculty-guided research projects.

"A research-grade instrument to make photosynthesis and water use measurements will enhance students' research experiences and increase the likelihood that their project results can be published in a peer-reviewed scientific journal," Tobin says in a release.

UHD opened the College of Sciences & Technology Building in August. It's the first University of Houston System building constructed to meet LEED Gold standards, reflecting a commitment to sustainability features such as energy-efficient lighting, recycled construction materials, and "smart" design components.

Spanning 105,000 square feet, the College of Sciences & Technology Building contains nearly 30 labs for teaching and research, as well as classrooms, meeting and study spaces, and a café. UHD envisions the building will be a "model for sustainability in Houston."

Environmental highlights of the building include a 6,000-gallon cistern that provides water for the outdoor urban gardens, and the addition of native grasses in the surrounding landscape to create a micro-pocket prairie and, in effect, an outdoor classroom.

Aside from classes and resources for students and faculty in biology, biotechnology, biological and physical sciences, and chemistry, the building houses UHD's Center for Urban Agriculture & Sustainability.

The center is "a game changer for UHD initiatives and scholarly activities centered on sustainability," Lisa Morano, director of the Center for Urban Agriculture & Sustainability, says in a release. "It also serves as an example of how planners and architects can incorporate environmentally sound decisions in the design and construction of academic facilities."

Juan Sánchez Muñoz, president of UHD, says the College of Sciences & Technology Building is a hub for academic exploration and a catalyst for community collaboration.

"Its labs and learning spaces will elevate UHD's ability to prepare the next generation of Houston's scientists and innovators. The facility also will serve as a place where Houstonians can gather to address issues affecting our city and to learn how UHD is leading positive change in the region," Muñoz says in a release. "It's a major addition to our campus and an incredible asset to Houston."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

5 Houston scientists named winners of prestigious Hill Prizes 2026

prized research

Five Houston scientists were recognized for their "high-risk, high-reward ideas and innovations" by Lyda Hill Philanthropies and the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST).

The 2026 Hill Prizes provide seed funding to top Texas researchers. This year's prizes were given out in seven categories, including biological sciences, engineering, medicine, physical sciences, public health and technology, and the new artificial intelligence award.

Each recipient’s institution or organization will receive $500,000 in direct funding from Dallas-based Lyda Hill Philanthropies. The organization has also committed to giving at least $1 million in discretionary research funding on an ad hoc basis for highly-ranked applicants who were not selected as recipients.

“It is with great pride that I congratulate this year’s Hill Prizes recipients. Their pioneering spirit and unwavering dedication to innovation are addressing some of the most pressing challenges of our time – from climate resilience and energy sustainability to medical breakthroughs and the future of artificial intelligence,” Lyda Hill, founder of Lyda Hill Philanthropies, said in a news release.

The 2026 Houston-area recipients include:

Biological Sciences: Susan M. Rosenberg, Baylor College of Medicine

Rosenberg and her team are developing ways to fight antibiotic resistance. The team will use the funding to screen a 14,000-compound drug library to identify additional candidates, study their mechanisms and test their ability to boost antibiotic effectiveness in animal models. The goal is to move toward clinical trials, beginning with veterans suffering from recurrent infections.

Medicine: Dr. Raghu Kalluri, The University of Texas MD Anderson Cancer Center

Kalluri is developing eye drops to treat age-related macular degeneration (AMD), the leading cause of vision loss globally. Kalluri will use the funding to accelerate studies and support testing for additional ocular conditions. He was also named to the National Academy of Inventors’ newest class of fellows last month.

Engineering: Naomi J. Halas, Rice University

Co-recipeints: Peter J. A. Nordlander and Hossein Robatjazi, Rice University

Halas and her team are working to advance light-driven technologies for sustainable ammonia synthesis. The team says it will use the funding to improve light-driven catalysts for converting nitrogen into ammonia, refine prototype reactors for practical deployment and partner with industry collaborators to advance larger-scale applications. Halas and Nordlander are co-founders of Syzygy Plasmonics, and Robatjazi serves as vice president of research for the company.

The other Texas-based recipients include:

  • Artificial Intelligence: Kristen Grauman, The University of Texas at Austin
  • Physical Sciences: Karen L. Wooley, Texas A&M University; Co-Recipient: Matthew Stone, Teysha Technologies
  • Public Health: Dr. Elizabeth C. Matsui, The University of Texas at Austin and Baylor College of Medicine
  • Technology: Kurt W. Swogger, Molecular Rebar Design LLC; Co-recipients: Clive Bosnyak, Molecular Rebar Design, and August Krupp, MR Rubber Business and Molecular Rebar Design LLC

Recipients will be recognized Feb. 2 during the TAMEST 2026 Annual Conference in San Antonio. They were determined by a committee of TAMEST members and endorsed by a committee of Texas Nobel and Breakthrough Prize Laureates and approved by the TAMEST Board of Directors.

“On behalf of TAMEST, we are honored to celebrate the 2026 Hill Prizes recipients. These outstanding innovators exemplify the excellence and ambition of Texas science and research,” Ganesh Thakur, TAMEST president and a distinguished professor at the University of Houston, added in the release. “Thanks to the visionary support of Lyda Hill Philanthropies, the Hill Prizes not only recognize transformative work but provide the resources to move bold ideas from the lab to life-changing solutions. We are proud to support their journeys and spotlight Texas as a global hub for scientific leadership.”

Investment bank opens new Houston office focused on energy sector

Investment bank Cohen & Co. Capital Markets has opened a Houston office to serve as the hub of its energy advisory business and has tapped investment banking veteran Rahul Jasuja as the office’s leader.

Jasuja joined Cohen & Co. Capital Markets, a subsidiary of financial services company Cohen & Co., as managing director, and head of energy and energy transition investment banking. Cohen’s capital markets arm closed $44 billion worth of deals last year.

Jasuja previously worked at energy-focused Houston investment bank Mast Capital Advisors, where he was managing director of investment banking. Before Mast Capital, Jasuja was director of energy investment banking in the Houston office of Wells Fargo Securities.

“Meeting rising [energy] demand will require disciplined capital allocation across traditional energy, sustainable fuels, and firm, dispatchable solutions such as nuclear and geothermal,” Jasuja said in a news release. “Houston remains the center of gravity where capital, operating expertise, and execution come together to make that transition investable.”

The Houston office will focus on four energy verticals:

  • Energy systems such as nuclear and geothermal
  • Energy supply chains
  • Energy-transition fuel and technology
  • Traditional energy
“We are making a committed investment in Houston because we believe the infrastructure powering AI, defense, and energy transition — from nuclear to rare-earth technology — represents the next secular cycle of value creation,” Jerry Serowik, head of Cohen & Co. Capital Markets, added in the release.

---

This article originally appeared on EnergyCaptialHTX.com.

MD Anderson makes AI partnership to advance precision oncology

AI Oncology

Few experts will disagree that data-driven medicine is one of the most certain ways forward for our health. However, actually adopting it comes at a steep curve. But what if using the technology were democratized?

This is the question that SOPHiA GENETICS has been seeking to answer since 2011 with its universal AI platform, SOPHiA DDM. The cloud-native system analyzes and interprets complex health care data across technologies and institutions, allowing hospitals and clinicians to gain clinically actionable insights faster and at scale.

The University of Texas MD Anderson Cancer Center has just announced its official collaboration with SOPHiA GENETICS to accelerate breakthroughs in precision oncology. Together, they are developing a novel sequencing oncology test, as well as creating several programs targeted at the research and development of additional technology.

That technology will allow the hospital to develop new ways to chart the growth and changes of tumors in real time, pick the best clinical trials and medications for patients and make genomic testing more reliable. Shashikant Kulkarni, deputy division head for Molecular Pathology, and Dr. J. Bryan, assistant professor, will lead the collaboration on MD Anderson’s end.

“Cancer research has evolved rapidly, and we have more health data available than ever before. Our collaboration with SOPHiA GENETICS reflects how our lab is evolving and integrating advanced analytics and AI to better interpret complex molecular information,” Dr. Donna Hansel, division head of Pathology and Laboratory Medicine at MD Anderson, said in a press release. “This collaboration will expand our ability to translate high-dimensional data into insights that can meaningfully advance research and precision oncology.”

SOPHiA GENETICS is based in Switzerland and France, and has its U.S. offices in Boston.

“This collaboration with MD Anderson amplifies our shared ambition to push the boundaries of what is possible in cancer research,” Dr. Philippe Menu, chief product officer and chief medical officer at SOPHiA GENETICS, added in the release. “With SOPHiA DDM as a unifying analytical layer, we are enabling new discoveries, accelerating breakthroughs in precision oncology and, most importantly, enabling patients around the globe to benefit from these innovations by bringing leading technologies to all geographies quickly and at scale.”